Effect of Rivoceranib 200 mg Once Daily on the Pharmacokinetics of a Cocktail Probe Substrate of Cytochrome P450 Enzymes: A Phase I Trial in Healthy Volunteers
1. 系统已在2026-09-11 14:39:59对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s40262-026-01686-6
文献链接: https://link.springer.com/10.1007/s40262-026-01686-6
其他信息:
出版社: Springer Science and Business Media LLC
作者: David Nguyen; Xiaohui Tracey Wei; Xianzhang Meng; Laura Alexander; Kristin Ryan; Seong Jang
全文下载地址: https://link.springer.com/content/pdf/10.1007/s40262-026-01686-6.pdf

